Dr. Martin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Taussig Cancer Center
10201 Carnegie Ave
Cleveland, OH 44106Phone+1 216-844-3951Fax+1 216-201-7435
Summary
- Dr. James Martin is a hematologist in Cleveland, OH and is affiliated with Case Western Reserve University/Cleveland Clinic. He received his medical degree from The Ohio State University College of Medicine and has been in practice 5 years.
Education & Training
Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
Brown UniversityResidency, Internal Medicine, 2013 - 2016
Ohio State University College of MedicineClass of 2013
Certifications & Licensure
OH State Medical License 2020 - 2026
PA State Medical License 2016 - 2021
RI State Medical License 2013 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Reduced-Dose Radiation Therapy and Concurrent Paclitaxel Chemotherapy in Lymph Node-Positive Breast Cancer: Long-Term Follow-up of a Single-Institution Prospective Study.Courtney E Pisano, Michael Z Kharouta, Eleanor E Harris, Robert Shenk, James Martin
International Journal of Radiation Oncology, Biology, Physics. 2023-11-15 - 4 citationsSystemic Therapies Following Progression on First-line CDK4/6-inhibitor Treatment: Analysis of Real-world Data.James M Martin, Elizabeth A Handorf, Alberto J Montero, Lori J Goldstein
The Oncologist. 2022-06-08 - 3 citationsCDK 4/6 Inhibitors: Evolution and Revolution in the Management of ER+ Metastatic Breast CancerPriyanka M Reddy, James M Martin, Alberto J. Montero
JCO Oncology Practice. 2021-10-12
Press Mentions
Targeted Therapies for Breast Cancer Increase Thrombosis RiskJanuary 22nd, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
